Sanofi ADR (SNY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $116.15B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sanofi ADR (SNY) Competitors
The companies most similar to Sanofi ADR are Novo Nordisk A/S (NVO), Pfizer (PFE) and Bristol-Myers Squibb Company (BMY). By market cap, Sanofi ADR ranks 11th of the 13 companies on this page; Eli Lilly and Company (LLY) is the largest at $1.29T. The median P/E of the 10 companies with a P/E is 20.7x.
Peer Comparison
SNY's ROIC of 7.6% is below the peer median of 13.9%, and its revenue growth of 15.7% is above the median of 6.8%. Its dividend yield is above the peer median of 2.35%.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Sanofi ADR (SNY) | $116.15B | N/A | 2.0x | 8.2% | 7.6% | 15.7% | 5.01% |
| Novo Nordisk A/S (NVO) | $183.52B | N/A | 3.6x | 33.9% | 34.1% | 5.6% | 4.32% |
| Pfizer Inc (PFE) | $164.67B | 9.5x | 2.6x | 6.3% | 2.7% | -0.4% | 5.96% |
| Bristol-Myers Squibb Company (BMY) | $129.66B | 10.1x | 2.6x | 18.5% | 13.9% | 6.9% | 4.00% |
| GSK plc (GSK) | $101.13B | 10.5x | 2.3x | 13.0% | N/A | 4.0% | 3.58% |
| Gilead Sciences Inc (GILD) | $208.48B | N/A | 6.7x | -12.5% | -3.9% | 6.8% | 1.96% |
| Novartis AG ADR (NVS) | $303.12B | 18.7x | 5.4x | 17.5% | 13.5% | 4.7% | 2.98% |
| Amgen Inc (AMGN) | $251.89B | 19.9x | 6.4x | 24.1% | 17.0% | 8.5% | 2.18% |
| AstraZeneca PLC (AZN) | $286.07B | 22.5x | 4.6x | 17.7% | 14.9% | 6.7% | 1.16% |
| Biogen Inc (BIIB) | $37.46B | 21.4x | 3.6x | 3.4% | 1.3% | 10.6% | 0.00% |
| Merck & Company Inc (MRK) | $364.26B | 46.3x | 5.3x | 3.6% | 3.1% | 4.7% | 2.35% |
| AbbVie Inc (ABBV) | $521.50B | 23.0x | 7.9x | 15.7% | 16.4% | 10.3% | 2.35% |
| Eli Lilly and Company (LLY) | $1.29T | 44.9x | 14.8x | 31.9% | 30.7% | 38.6% | 0.48% |
| Peer median | $230.18B | 20.7x | 5.0x | 16.6% | 13.9% | 6.8% | 2.35% |
Similar Companies
These are the 12 companies most similar to Sanofi ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.
| Company | About | Peers |
|---|---|---|
| Novo Nordisk A/S (NVO) | Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. | NVO competitors |
| Pfizer Inc (PFE) | Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. | PFE competitors |
| Bristol-Myers Squibb Company (BMY) | Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. | BMY competitors |
| GSK plc (GSK) | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines... | GSK competitors |
| Gilead Sciences Inc (GILD) | Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California... | GILD competitors |
| Novartis AG ADR (NVS) | Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland. | NVS competitors |
| Amgen Inc (AMGN) | Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. | AMGN competitors |
| AstraZeneca PLC (AZN) | AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory... | AZN competitors |
| Biogen Inc (BIIB) | Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development... | BIIB competitors |
| Merck & Company Inc (MRK) | Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. | MRK competitors |
| AbbVie Inc (ABBV) | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. | ABBV competitors |
| Eli Lilly and Company (LLY) | Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. | LLY competitors |
Frequently Asked Questions About SNY
Who are Sanofi ADR's main competitors?
The companies most similar to Sanofi ADR include Novo Nordisk A/S (NVO), Pfizer (PFE), Bristol-Myers Squibb Company (BMY), GSK (GSK) and Gilead Sciences (GILD), listed from the closest match.
Who is Sanofi ADR's biggest competitor?
Eli Lilly and Company (LLY) is the largest of the similar companies at $1.29T; Novo Nordisk A/S (NVO) is the closest match by business profile, size, sector and industry.
How does SNY stock compare with its competitors?
SNY's P/S is 2.0x against a peer median of 5.0x; its net margin is 8.2% against a peer median of 16.6%.
Which of Sanofi ADR's competitors pays a higher dividend?
Sanofi ADR has a forward dividend yield of 5.01%. Pfizer (PFE) has a higher forward dividend yield; Pfizer (PFE) has the highest at 5.96%.
Is Sanofi ADR bigger than its competitors?
No. Sanofi ADR is 11th by market cap among the 13 companies on this page; the largest is Eli Lilly and Company (LLY) at $1.29T.
SNY pages: Overview, Dividends, Financials, Valuation, Competitors, Government Contracts